Baird’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Baird’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$416K	Sell	5,440 -4,133	-43%	-$304K	﹤0.01%	1012
2014 Q4	$637K	Sell	9,573 -14,348	-60%	-$956K	0.01%	871
2014 Q3	$1.52M	Sell	23,921 -32	-0.1%	-$1.98K	0.02%	531
2014 Q2	$1.46M	Buy	23,953 +18,495	+339%	+$1.07M	0.02%	564
2014 Q1	$309K	Sell	5,458 -20	-0.4%	-$1.14K	﹤0.01%	977
2013 Q4	$293K	Buy	5,478 +813	+17%	+$40.7K	0.01%	975
2013 Q3	$215K	Sell	4,665 -18,275	-80%	-$834K	﹤0.01%	1012
2013 Q2	$969K	Buy	+22,940	New	+$955K	0.02%	578

Other funds holding PJP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

FIG

FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

Baird's PJP Position: Q1 2015 in Review

Baird reduced its Invesco Pharmaceuticals ETF (PJP) stake by 43% in Q1 2015, selling an estimated $304K and leaving 5,440 shares worth $416K. The position accounts for ﹤0.01% of the portfolio, ranked #1012.

Baird first reported a position in PJP in Q2 2013 and has held it in 8 quarters since. The position peaked at $1.52M in Q3 2014. 105 funds tracked by Wall St. Rank hold PJP as of Q1 2015.

Baird held 5,440 shares of Invesco Pharmaceuticals ETF worth $416K as of Q1 2015.
Baird sold 4,133 Invesco Pharmaceuticals ETF shares in Q1 2015, an estimated $304K.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Baird's portfolio in Q1 2015, its #1012 holding.
Baird first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 8 quarters since.
Baird's Invesco Pharmaceuticals ETF position peaked at $1.52M in Q3 2014.
105 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.